Canterbury DHB



As MRD is part of the treatment strategy for AML19, patients do not receive maintenance therapy. Patients should be advised that marrow samples will be taken after each consolidation course and at 3 monthly intervals for 36 months.

About this Canterbury DHB document (32136):

Document Owner:

Blake Hsu (see Who's Who)

Last Reviewed:

October 2018

Next Review:

October 2020


Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 32136